Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Clinical trial NCT00516100 · UNKNOWN

Trial details

NCT number: NCT00516100
Sponsor: Aptium Oncology Research Network
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2006-01-01
Primary completion: 2010-01-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.